FDA’s “Whole Hearted” Approach To Cardiac Device Research
This article was originally published in The Gray Sheet
FDA’s Biophysics Lab is performing cardiac electrophysiology research aimed at improving industry’s clinical studies.
You may also be interested in...
FDA’s Office of Science and Engineering Laboratories provided 12% more consults on pre-market issues in 2011 than the year before.
FDA wants to better understand computer modeling methods - such as programs that simulate the performance of heart valves in the body - and help companies incorporate such tests into pre-market device applications
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients